In The News
NeOnc Technologies Holdings is committed to providing the latest information on its patented and novel drug-delivery technology platform. The following offers media releases related to the company and its progress.
Focused on Development of Innovative Drug Delivery Solutions
Jan 5, 2025
The Man Behind the Mission: Dr. Thomas Chen’s Vision for Brain Cancer Treatment
Dec 2, 2024
Innovative strategy: NeOnc’s bold move in biotech
Nov. 20, 2024
How Professors Can Foster Innovation Amongst The Students They Teach
Nov. 11, 2024
Amir Heshmatpour: Transforming Oncology Research with Visionary Leadership and Innovation
Oct. 22, 2024
NeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024
Oct. 7, 2024
Pharmacy Focus – Oncology Edition: Advancing Brain Cancer Research and Treatment
Sept. 26, 2024
A Biotech Going Through The Nose To Treat The Brian Plots Alternative Path To Public Markets
Sept. 8,2024
NeOnc – A Novel Approach To Treating Brain Cancer
Aug 19,2024
The Man Behind the Mission: Dr. Thomas Chen’s Vision for Brain Cancer Treatment.
Aug 7,2024
Meet the Surgeon Leading a Biotech Revolution: Dr. Thomas Chen’s Fight Against Brain Cancer.
Aug 6, 2024
From Terminal To Thriving: Real Patient Outcomes With NeOnc’s Treatment.
July 29, 2024
NeOnc Noses Into Novel Brain Cancer Treatment.
July 25,2024
Venture Capital Post Discusses NeOnc’s Path To A Direct Public Offering.
July 15, 2024
Healing at Home: How NeOnc’s Innovative Treatment Brings Brain Cancer Care to Patients’ Doorsteps.
July 15, 2024
Revolutionizing Brain Cancer Treatment: NeOnc Introduces First Non-Invasive Intranasal Drug Delivery for Brain Cancer.
July 12, 2024
Pioneering Non-Invasive Treatments: NeOnc’s Breakthrough in Brain Cancer Care.
July 10, 2024